A study conducted by a group of Brazilian researchers contributes to a deeper understanding of the molecular basis for schizophrenia, and potentially to the development of more specific and effective treatments for the disease. ...
Jun 7, 2021
0
3
Scientists at the Laboratoire des Maladies Neurodégénératives (CNRS/CEA/Université Paris-Saclay) and the Neurocentre Magendie (INSERM/Université de Bordeaux) have just shown that a metabolic pathway plays a determining ...
Mar 3, 2020
0
13
Ketamine has gotten a bad rap as an opioid when there's plenty of evidence suggesting it isn't one, Johns Hopkins experts say. They believe this reputation may hamper patients from getting necessary treatment for the kinds ...
Jul 31, 2019
1
202
Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers ...
Jul 3, 2019
0
2
Russian scientists investigated the changes in the temporal lobe cortex of a rat brain during prolonged epileptic seizures. Despite the complex interaction of neural signals, biologists and physicists managed to build their ...
Jan 8, 2019
0
2
Protective proteins that mitigate the destruction of nerve cells after a stroke can be administered into the brain through the nose, as Heidelberg University researchers demonstrated using a mouse model. The team led by Prof. ...
Aug 24, 2018
0
2
In contrast to most antidepressant medications, which can take several weeks to reduce depressive symptoms, ketamine—a commonly used veterinary anesthetic—can lift a person out of a deep depression within minutes of its ...
Jun 21, 2018
0
619
New research has identified the way age impairs the ability of the circadian clock in mammals to re-set itself when exposed to light, resulting in disruption to sleeping patterns and consequent threats to wellbeing.
Mar 27, 2018
0
63
A new study of young people experiencing a first episode of psychosis reports elevations in the brain chemicals glutamate and glycine. Published in Biological Psychiatry, the study led by Dr. Dost Öngür of Harvard Medical ...
Oct 11, 2017
0
8
Inserm Unit U919, directed by Prof. Denis Vivien ("Serine Proteases and Physiopathology of the Neurovascular Unit") has developed an antibody with potential therapeutic effects against multiple sclerosis. The study, directed ...
Jul 20, 2016
0
41
